Mark Cicacci

Mark Cicacci is a seasoned professional with extensive experience in the biopharmaceutical industry, currently serving as the Sr. Area Business Leader for Eisai US since December 2023. Prior to this role, Mark held several key positions, including Regional Business Director for Fresenius Kabi USA, where focus was on biosimilars in the Northeast, and Regional Sales Director for Flexion Therapeutics, leading the launch of Zilretta and earning recognition as a 2020 President Club Winner. Mark's career also includes advisory roles in commercial strategy at Naia Pharmaceuticals, building teams and driving sales efforts for rare disease products at Shire and NPS Pharmaceuticals, and managing specialty sales teams at UCB and Biogen. Mark holds a BS in Business Administration with a concentration in Marketing from King's College.